Clinical Trial Update: Hyperbaric High Pressure Oxygen Therapy in Post-COVID Syndrome and ME/CFS

View source ↗

Summary

A completed Charite University Berlin clinical trial evaluated hyperbaric high-pressure oxygen therapy for Post-COVID-19 condition and myalgic encephalomyelitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myalgic Encephalomyelitis Chronic Fatigue Syndrome
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Hyperbaric Oxygen Therapy

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Post-COVID ME/CFS | Status: COMPLETED